Abstract
Objectives
To review and report our local experience in the management of ductal adenocarcinoma of the prostate.
Methods
Retrospective review of patients diagnosed with ductal adenocarcinoma of the prostate in two regional urological centres in Hong Kong during 1995–2009. Clinical information, treatment and outcomes were retrieved for further analysis.
Results
We identified 19 Chinese patients diagnosed with ductal adenocarcinoma of the prostate. Majority of our patients presented with retention of urine and haematuria. At presentation, seven patients were already at an advanced stage with evidence of rectal invasion or distant metastasis. The overall treatment outcome was poor with high failure rate after either local or systemic hormonal therapy.
Conclusion
We observed a predilection of this tumour to be locally aggressive, and hence a relatively high incidence of intra-luminal growth and rectal invasion. We observed a high failure rate after either radical prostatectomy or hormonal therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Humphrey PA (2012) Histological variants of prostatic carcinoma and their significance. Histopathology 60(1):59–74
Melicow MM, Pachter MR (1967) Endometrial carcinoma of prostatic utricle (uterus masculinus). Cancer 20(10):1715–1722
Greene LF, Farrow GM, Ravits JM et al (1979) Prostatic adenocarcinoma of ductal origin. J Urol 121(3):303–305
Bostwick DG, Kindrachuk RW, Rouse RV (1985) Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol 9(8):595–609
Epstein JI, Woodruff JM (1986) Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases. Cancer 57(1):111–119
Bock BJ, Bostwick DG (1999) Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol 23(7):781–785
Christensen WN, Steinberg G, Walsh PC et al (1991) Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer 67(8):2118–2124
Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL (2010) Ductal adenocarcinoma of the prostate: increase mortality risk and decreased serum prostate specific antigen. J Urol 184(6):2303–2307
Meeks JJ, Zhao LC, Cashy J, Kundu S (2012) Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the surveillance, epidemiology, and end results program. BJU Int 109(6):831–834
Rubin MA, de la Taille A, Bagiella E et al (1998) Cribriform carcinoma of the prostate and cribriform prostate intraepithelial neoplasia: incidence and clinical implications. Am J Surg Pathol 22(7):840–848
Wilcox G, Soh S, Chakraborty S et al (1998) Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum Pathol 29(10):1119–1123
Brinker DA, Potter SR, Epstein JI (1999) Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol 23(12):1471–1479
Xia SJ, Cui D, Jiang Q (2012) An overview of prostate diseases and their characteristics specific to Asian men. Asian J Androl 14(3):458–464
Cullen J, Elsamanoudi S, Brassell SA, Chen Y, Colombo M, Srivastava A, McLeod DG (2012) The burden of prostate cancer in Asian nations. J Carcinog 11:61–69
Yoon DK, Park JY, Yoon S, Park MS, du Moon G, Lee JG, Schroder FH (2012) Can the prostate risk calculator based on Western population be applied to Asian population? Prostate 72(7):721–729
Fujino A (1998) A case of prostatic ductal adenocarcinoma with endometrioid features, associated with rectal invasion and multiple liver metastases. Jpn J Urol 89(9):792–795
Nishihara C, Kuratsukuri K, Tanaka T, Kawashima H, Nakatani T (2011) Successful combined treatment with maximal androgen blockade (MAB), intra arterial chemotherapy and radiation for advanced prostatic ductal adenocarcinoma: report of two cases. Acta Urol Jpn 57(4):209–212
Ohyama C, Takyu S, Yoshikawa K, Suzuki H, Tezuka F, Hasuda A, Inaba Y, Hoshi S, Orikasa S (2001) Adenocarcinoma arising from the prostatic duct mimicking transitional cell carcinoma. Int J Urol 8(7):408–411
Suzuki T, Shinbo H, Kurita Y, Furuse H, Mugiya S, Ozono S (2011) A case of ductal adenocarcinoma of the prostate treated with endocrine therapy and radiation therapy. Acta Urol Jpn 57(5):261–264
Cheng CJ, Chen KC, Chen WY, Su SJ (2001) Ductal adenocarcinoma of the prostate with endometrioid features in a 69-year-old man. J Formos Med Assoc 100(10):707–711
Chuang AY, Chang SJ, Horng CF, Tsou MH (2007) Study of prostate cancer pathologic features in Chinese populations. Urology 69(5):915–920
Orihuela E, Green JM (2008) Ductal prostate cancer: contemporary management and outcomes. Urol Oncol 26(4):368–371
Shazer RL, Luthringer D, Agus DB, Gross ME (2004) Ductal adenocarcinoma of the prostate. Clin Adv Hematol Oncol 2(6):393–395
Epstein JI (2010) Prostatic ductal adenocarcinoma: a mini review. Med Princ Pract 19(1):82–85
Epstein JI (2010) An update of the Gleason grading system. J Urol 183(2):433–440
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kan, R.W.M., Kan, C.F., Wong, J.H.M. et al. Ductal adenocarcinoma of the prostate: a Hong Kong case series. Int Urol Nephrol 46, 2133–2137 (2014). https://doi.org/10.1007/s11255-014-0793-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0793-z